Vivek Ramaswamy Sells 3,000,000 Shares of Roivant Sciences Ltd. (NASDAQ:ROIV) Stock

Vivek Ramaswamy is a businessman and entrepreneur who co-founded Roivant Sciences Ltd., a biopharmaceutical company that focuses on developing and commercializing drugs for various diseases. On August 10, 2021, Ramaswamy sold 3,000,000 shares of Roivant Sciences Ltd.'s common stock through a registered direct offering to institutional investors. The sale was made at an average price of $45.79 per share, generating gross proceeds of approximately $137 million for the company.

Roivant Sciences Ltd. is headquartered in New York City and has operations in several countries, including the United States, China, and Europe. The company's portfolio includes several drugs that are in various stages of development, including a potential treatment for multiple sclerosis and a potential treatment for Alzheimer's disease. Roivant Sciences Ltd.'s stock is listed on the NASDAQ Global Select Market under the ticker symbol "ROIV."